Dynamic Technology Solutions Introduces a Self-Diagnostic Tool that Measures Product End-of-Life Risk Exposure

Dynamic's 10-Question "EOL Prep[SM]" Enables Companies to Evaluate and Strengthen Product End-of-Life Risk Management Capabilities

Dynamic Technology Solutions (Dynamic) announced today the introduction of its EOL PrepSM Self-Diagnostic, based on industry best practices, that provides insights into how well a company is managing risks associated with product End-of-Life (EOL).

Product End-of-Life planning is often the most critical phase of technology lifecycle management, particularly for complex businesses – such as medical device manufacturing – where the consequences of disruption or product failure can be significant.

End-of-life issues become a priority when an equipment manufacturer no longer produces, sells, or provides upgrades, fixes or other related services for essential technology hardware or software. Without advanced awareness and proper planning, these changes can make essential products or entire systems inoperable.

To address that need, and based on its deep experience in product EOL and lifecycle management, Dynamic has created the EOL PrepSM Self-Diagnostic, consisting of 10 questions that enable companies to:

  • Identify specific protections and vulnerabilities related to their product EOL exposure;
  • Understand the complete range of EOL best practices they should follow;
  • Prioritize the EOL capabilities that need to be established or improved;
  • Create a tailored action plan designed to reduce their EOL-related risks.

Dynamic’s CEO and President, Farida Ali, noted that, “For companies that do not have any EOL risk management disciplines in place, that task can seem complex and daunting. Conversely, for companies that do have relevant EOL-related processes and procedures, there is always the risk of operating with outdated or insufficient protections. In both cases, application of our EOL PrepSM  provides a fast and effective way to either design or strengthen an effective risk management strategy.”

Dynamic’s EOL PrepSM Self-Diagnostic is available on a complimentary basis to industry professionals on request, by clicking here. Dynamic’s product lifecycle management professionals welcome the opportunity to provide additional insights into use of its EOL self-diagnostic tool, and to answer any questions regarding the firm’s product lifecycle risk management capabilities.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version